Advertisement
Screener

Theravance Biopharma, Inc. (TBPH) Effective Income Tax Rate Reconciliation, Tax Contingency, Percent

2.5 / 5 stars · 43/85 Roast Me

Theravance Biopharma, Inc. Effective Income Tax Rate Reconciliation, Tax Contingency, Percent

Theravance Biopharma, Inc. (TBPH) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Percent of -21.19% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-23.

Financial Statements › Expense Statement › Income Tax

us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies · last filed 2026-03-23

  • Theravance Biopharma, Inc. effective income tax rate reconciliation, tax contingency, percent for fiscal 2024 was -21.19%.
  • Theravance Biopharma, Inc. effective income tax rate reconciliation, tax contingency, percent for fiscal 2017 was -6.55%.
  • Theravance Biopharma, Inc. effective income tax rate reconciliation, tax contingency, percent for fiscal 2016 was -8.55%.
  • Theravance Biopharma, Inc. effective income tax rate reconciliation, tax contingency, percent for fiscal 2015 was -3.88%.
Period endEffective Income Tax Rate Reconciliation, Tax Contingency, Percent 12 month
2024-12-31-21.19%
10-K · filed 2026-03-23
2017-12-31-6.55%
10-K · filed 2018-02-28
2016-12-31-8.55%
10-K · filed 2018-02-28
2015-12-31-3.88%
10-K · filed 2018-02-28
2014-12-31-0.25%
10-K · filed 2017-03-01
2013-12-310.00%
10-K · filed 2016-03-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cryoport, Inc. (CYRX)United States$0.881B-21.29
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
Apnimed, Inc. (APMD)United States$0.899B
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71